BSE filing, NSE: BACPHAR. Summary written from the filing by ALFA Finder's alert engine.
Bacil Pharma Ltd: key numbers
- Share price
- ₹18.81
- Market cap
- ₹27.00 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 42.7×Sector 45.9×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bacil Pharma Ltd
All →Bacil Pharma Other Announcement
Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr
Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Bacil Pharma Management Change
Mr. Dikshant Singh Panwar has resigned as Whole-Time Company Secretary and Compliance Officer of Bacil Pharma Limited, effective October 8, 2026.
Bacil Pharma Board Meeting Date
Bacil Pharma will hold a board meeting on October 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Bacil Pharma Annual Report
Bacil Pharma Limited submitted its 39th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 23, 2026, via video conferencing.
Bacil Pharma Annual General Meeting
Bacil Pharma Limited has announced book closure dates from September 17 to September 23, 2026, for its 39th Annual General Meeting.
Other merger & restructuring announcements
All →KS Smart Technologies Merger & Restructuring Worth ₹0.01 Cr
KS Smart Technologies reported completion of a foreign subsidiary's incorporation, KS Smart Global Inc. in USA, on 22 October 2026. Transaction amount is ₹0.01 Crore.
- Value
- ₹0.01 Cr
KS Smart Technologies Merger & Restructuring
KS Smart Technologies reported that its step-down subsidiary KS Smart Global Inc. was incorporated in Delaware, USA, on October 22, 2026. The initial share subscription is stated as up to USD 510, held 51% by KSSPL.
AXISCADES Technologies Merger & Restructuring
AXISCADES Technologies disclosed that its step-down subsidiary Ulosia Holding AG incorporated AKKODIS AXISCADES AEROSPACE CANADA INC. in Canada. No cash was invested by the listed entity, and no value is stated.
Sapphire Foods India Merger & Restructuring
Sapphire Foods received CCI approval under Section 31(1) for its proposed merger into Devyani International under a Scheme of Arrangement. The detailed CCI order is still awaited.
Aditya Ispat Merger & Restructuring
Aditya Ispat's steel slump sale to related party Jai Bapji Ispat now completes by 31 December 2026. Delay stems from pre-closing actions under the business transfer agreement.
Vahh Chemicals Merger & Restructuring Worth ₹0.1 Cr
VAHH Chemicals will incorporate Vedant Nutrition Limited as a wholly owned nutraceutical subsidiary with Rs 0.10 Crore cash. Incorporation is tentatively dated November 5, 2026.
- Value
- ₹0.10 Cr